Ocular Therapeutix Inc
F:0OT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Ocular Therapeutix Inc
F:0OT
|
US |
|
iMetal Resources Inc
F:A7V
|
CA |
|
Literacy Capital PLC
F:26W
|
UK |
|
T
|
TC Biopharm (Holdings) PLC
OTC:TCBPY
|
UK |
|
C
|
Cub Energy Inc
F:P36
|
US |
|
Indopoly Swakarsa Industry Tbk PT
IDX:IPOL
|
ID |
|
M
|
MeatBox Global Inc
KOSDAQ:475460
|
KR |
|
I
|
Innoveren Scientific Inc
OTC:IVRN
|
US |
|
A
|
Acerinox SA
DUS:ACE1
|
ES |
Wall St Price Targets
0OT Price Targets Summary
Ocular Therapeutix Inc
According to Wall Street analysts, the average 1-year price target for
0OT is 32.59 EUR with a low forecast of 21.73 EUR and a high forecast of 42.67 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0OT's stock price target?
Price Target
32.59
EUR
According to Wall Street analysts, the average 1-year price target for
0OT is 32.59 EUR with a low forecast of 21.73 EUR and a high forecast of 42.67 EUR.
What is the Revenue forecast for Ocular Therapeutix Inc?
Projected CAGR
60%
The compound annual growth rate for Revenue over the next 8 years is 60%.
What is the Gross Profit forecast for Ocular Therapeutix Inc?
Projected CAGR
61%
The compound annual growth rate for Gross Profit over the next 8 years is 61%.